PSAT1 Regulated Oxidation-Reduction Balance Affects the Growth and Prognosis of Epithelial Ovarian Cancer
Yiqun Zhang et al, 2020, OncoTargets and Therapy CrossRef
Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers Yuping Chen et al, 2023, Current Cancer Drug Targets CrossRef
miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells Huiling Wang et al, 2023, Genes & Genomics CrossRef
An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy Mingtao Feng et al, 2022, Frontiers in Genetics CrossRef
Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy Jing Zhang et al, 2023, Frontiers in Oncology CrossRef
The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment Xijia Zhou et al, 2023, Frontiers in Genetics CrossRef
Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma Huan Chen et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
Development of Novel Cancer Biomarkers for Diagnosis and Prognosis Kholood Abid Janjua et al, 2022, Cancer Biomarkers in Diagnosis and Therapeutics CrossRef
Therapeutic potential of targeting HSPA5 through dual regulation of two candidate prognostic biomarkers ANXA1 and PSAT1 in osteosarcoma Xiaojun Tang et al, 2021, Aging CrossRef